Watson Pharmaceuticals Inc. said it has received approval from the U.S. Food and Drug Administration to market a new generic drug for the treatment of depression.
From: www.pe.com
Local Business Briefs - 06/15/07
Posted by Ruslan Abuzant at 3:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment